Mayne Pharma (ASX:MYX) sells Metrics Contract Services for US$475m
Mayne Pharma (MYX) is selling its long time subsidiary Metrics Contract Services…
Change | ||
S&P/ASX Sm. Ords. | |||
All Ordinaries | |||
S&P/ASX 100 |
IRX | INHALERX LIMITED | 8.0¢ | 42.9% |
PGY | PILOT ENERGY LIMITED | 2.3¢ | 32.4% |
KOR | KORAB RESOURCES LIMITED | 3.5¢ | 29.6% |
CXU | CAULDRON ENERGY LIMITED | 0.9¢ | 18.2% |
AVH | AVITA MEDICAL INC. | $1.92 | 15.6% |
RAS | RAGUSA MINERALS LTD | 14.0¢ | 15.2% |
Date | Announcement | File | Views |
---|---|---|---|
10/08/2022 | Ceasing to be a substantial holder | 200.15KB | 2.6K |
10/08/2022 | Price Sensitive PS Mayne Pharma announces sale of Metrics Contract Services | 189.91KB | 23K |
08/08/2022 | FDA approval of HALOETTE, a generic version of NUVARING | 214.84KB | 6.4K |
02/08/2022 | Change of Director's Interest Notice | 258.05KB | 325 |
02/08/2022 | Notification of cessation of securities - MYX | 21.69KB | 179 |
02/08/2022 | NEXTSTELLIS nominated for 2022 Prix Galien USA Award | 182.5KB | 1.4K |
02/08/2022 | Update - Notification of buy-back - MYX | 24.12KB | 273 |
29/07/2022 | MYX and GoodRx announce NEXTSTELLIS DTC campaign | 247.79KB | 1.8K |